Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001500:BCG Vaccine; D001943:Breast Neoplasms / Q000188:drug therapy / Q000628:therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008408:Mastectomy; D008727:Methotrexate / Q000627:therapeutic use; D009163:Mycobacterium bovis; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D002699:Chlorambucil; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate